TY  - JOUR

T1  - Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN®Basal-Bolus Type 1): 2-year results of a randomized clinical trial

JO  - Diabetic Medicine

PY  - 2013/01/01

AU  - Bode BW

AU  - Buse JB

AU  - Fisher M

AU  - Garg SK

AU  - Marre M

AU  - Merker L

AU  - Renard E

AU  - Russell-Jones DL

AU  - Hansen CT

AU  - Rana A

AU  - Heller SR

ED  - 

DO  - DOI: 10.1111/dme.12243

PB  - Wiley

VL  - 30

IS  - 11

SP  - 1293

EP  - 1297

Y2  - 2024/12/22

ER  -